13F-HR filed by Ghost Tree Capital, LLC
Ghost Tree Capital, LLC filed this 13F-HR for the quarter ended 2017-09-30, filed 2017-11-14, with 63 holding rows worth $470,905,000.
- Accession
- 0001387131-17-005488
- Filer
- CIK 1595851
- Filed
- 2017-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2017
A holdings report, 63 entries on the cover page, a total value of $470,905,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $470,905,000 with VALUE read as thousands by filing date, 13F file number 028-16059. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPDR SER TR | 78464A870 | S&P BIOTECH | 350,000 | $30,300,000 | thousands by filing date | put |
| IMMUNOMEDICS INC | 452907108 | COM | 1,946,946 | $27,218,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 650,000 | $22,783,000 | thousands by filing date | put |
| ZOGENIX INC. | 98978L204 | Common Stock | 600,000 | $21,030,000 | thousands by filing date | |
| AVEXIS INC | 05366U100 | COM | 200,000 | $19,346,000 | thousands by filing date | put |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 420,886 | $17,862,000 | thousands by filing date | |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 403,500 | $17,125,000 | thousands by filing date | put |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 100,000 | $14,029,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 225,000 | $13,788,000 | thousands by filing date | |
| ACCELERON PHARMA INC | 00434H108 | COM | 350,000 | $13,062,000 | thousands by filing date | |
| NEVRO CORP | 64157F103 | COM | 115,000 | $10,451,000 | thousands by filing date | |
| ENTELLUS MED INC | 29363K105 | COM | 561,510 | $10,365,000 | thousands by filing date | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 324,400 | $10,125,000 | thousands by filing date | |
| AVEXIS INC | 05366U100 | COM | 104,539 | $10,112,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 150,000 | $9,561,000 | thousands by filing date | call |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 50,000 | $9,460,000 | thousands by filing date | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 300,000 | $9,363,000 | thousands by filing date | call |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 150,000 | $9,345,000 | thousands by filing date | put |
| GENMARK DIAGNOSTICS INC | 372309104 | COM | 950,000 | $9,149,000 | thousands by filing date | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 75,000 | $8,782,000 | thousands by filing date | |
| Boston Scientific Corporation | 101137107 | COM | 275,000 | $8,022,000 | thousands by filing date | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 65,000 | $7,784,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 250,000 | $7,763,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 50,000 | $7,602,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 200,000 | $7,250,000 | thousands by filing date | |
| SPARK THERAPEUTICS INC | 84652J103 | COM | 80,000 | $7,133,000 | thousands by filing date | |
| IRHYTHM HOLDINGS INC COM | 450056106 | Stock | 135,000 | $7,004,000 | thousands by filing date | |
| IGNYTA INC | 451731103 | COM | 550,000 | $6,793,000 | thousands by filing date | |
| PATTERSON COS INC | 703395103 | COM | 160,000 | $6,184,000 | thousands by filing date | |
| INTERCEPT PHARMACEUTICALS IN | 45845P108 | COM | 100,000 | $5,804,000 | thousands by filing date | call |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 252,534 | $5,710,000 | thousands by filing date | |
| AQUINOX PHARMACEUTICALS INC | 03842B101 | COM | 400,000 | $5,676,000 | thousands by filing date | |
| NANOSTRING TECHNOLOGIES INC | 63009R109 | COM | 345,284 | $5,580,000 | thousands by filing date | |
| GW PHARMACEUTICALS PLC | 36197T103 | ADS | 50,000 | $5,075,000 | thousands by filing date | |
| AIMMUNE THERAPEUTICS INC. | 00900T107 | Common Stock | 200,000 | $4,958,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 75,000 | $4,781,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 100,000 | $4,536,000 | thousands by filing date | |
| JUNO THERAPEUTICS INC | 48205A109 | COM | 100,000 | $4,486,000 | thousands by filing date | |
| Merck & Co.,Inc. | 58933Y105 | COM | 65,000 | $4,162,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 35,000 | $4,112,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 109,000 | $4,106,000 | thousands by filing date | call |
| INCYTE CORP COM | 45337C102 | Stock | 35,000 | $4,086,000 | thousands by filing date | |
| Viewra, Inc | 92672L107 | COM | 700,000 | $4,032,000 | thousands by filing date | |
| CURRENCYSHS BRIT POUND STER | 23129S106 | BRIT POUND STE | 30,100 | $3,923,000 | thousands by filing date | |
| AIMMUNE THERAPEUTICS INC. | 00900T107 | Common Stock | 150,000 | $3,719,000 | thousands by filing date | call |
| NEOS THERAPEUTICS INC | 64052L106 | COM | 400,000 | $3,660,000 | thousands by filing date | |
| AERIE PHARMACEUTICALS INC | 00771V108 | COM | 75,000 | $3,645,000 | thousands by filing date | |
| RA PHARMACEUTICALS INC | 74933V108 | COM | 235,000 | $3,431,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 200,000 | $3,016,000 | thousands by filing date | |
| KADMON HLDGS INC | 48283N106 | COM | 850,000 | $2,848,000 | thousands by filing date | |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 1,100,000 | $2,794,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 500,000 | $2,620,000 | thousands by filing date | |
| INTERCEPT PHARMACEUTICALS IN | 45845P108 | COM | 35,000 | $2,031,000 | thousands by filing date | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 100,000 | $2,001,000 | thousands by filing date | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 100,000 | $2,001,000 | thousands by filing date | call |
| IRIDEX CORP | 462684101 | COM | 199,519 | $1,869,000 | thousands by filing date | |
| NUVASIVE INC | 670704105 | COM | 30,000 | $1,664,000 | thousands by filing date | |
| EXELIXIS INC COM | 30161Q104 | Stock | 53,500 | $1,296,000 | thousands by filing date | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 64,410 | $1,223,000 | thousands by filing date | |
| NABRIVA THERAPEUTICS PLC | G63637105 | SHS | 120,000 | $983,000 | thousands by filing date | |
| QUOTIENT LTD | G73268107 | SHS | 187,450 | $924,000 | thousands by filing date | |
| AXOVANT SCIENCES LTD | G0750W104 | COM | 100,000 | $688,000 | thousands by filing date | |
| VERSARTIS INC | 92529L102 | COM | 275,000 | $674,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001387131-17-005488 | this filing | 2017-11-14 | acceptance time not in the bulk data set |